Inicio > Anatomía Patológica > Caracterización anatomopatológica del carcinoma renal > Página 4

Caracterización anatomopatológica del carcinoma renal

Referencias Bibliográficas:

  1. Escudier B & Kataja V. Clinical recommendations. Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. On behalf of the ESMO Guidelines Working Group. Annals of Oncology 20 (Supplement 4): iv81- iv82, 2009
  2. Greene FL, Page DL, Fleming ID et al. (2002) AJCC cancer staging manual, Springer, Berlin.
  3. The NCCN Clinical Practice Guidelines in Oncology™ Kidney Cancer (Version 2.2010) en
  4. Fyfe G, Fisher RI, Rosenberg SA et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 13: 688–696, 1995.
  5. Motzer RJ, Rini BI, Bukowski RM et al. Sunitinib in patients with metastatic renalcell carcinoma. JAMA 295: 2516–2524, 2006
  6.  Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma. N Engl J Med 356:115, 2007
  7.  Hudes G, Carducci M, Tomczak P et al. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma. N Engl J Med 356:2271, 2007
  8. Motzer RJ. Renal Cell Cancer: DIagnosis and Therapy. N Engl J Med 360:1916, 2009. Book Review
  9. B. J. Escudier, J. Bellmunt, S. Negrier et al. Final results of the phase III, randomized, double-blind AVOREN trial of first-line bevacizumab (BEV) + interferon-α2a (IFN) in metastatic renal cell carcinoma (mRCC). J Clin Oncol 27:15s, 2009 (suppl; abstr 5020). ASCO 2009.
  10. Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125–134, 2007.
  11. Motzer RJ, Escudier B, Oudard S et al. Everolimus for advanced renal cell carcinoma. Lancet 372: 449–456, 2008.
  12. Guidelines On Renal Cell Carcinoma. B. Ljungberg, D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu. European Association Of Urology 2008.
  13. American College Of Radiology. Acr Appropriateness CriteriaR. Renal Cell Carcinoma Staging. Date Of Origin: 1995 Last Review Date: 2007.
  14. Guía De Recomendaciones Para La Correcta Solicitud De Pruebas De Diagnóstico por Imagenes – 2008. Sociedad Argentina De Radiologia.
  15. Richard L. Wahl. Principles And Practice Of Pet/Tc (Second Edition). Lippincott Williams And Wilfins. Chapter 8.18 Genitourinary Malignancies; 366-391.
  16. Kimryn Rathmell W, Md, Phd, Walter M. Stadler, Md, Facp, And Brian I. Rini, Md. Rational Therapeutic Choices And Strategies For Patients With Metastatic Renal Cancer. 2008 American Society Of Clinical Oncology. 1092-9118/07/192-198.
  17. N Reed Dunnick, Carl M Sandler, Jeffrey H Newhouse, E Stephen Amis, Jr. Textbook Of Uroradiology, Fourth Edition. Wolters Kluwer Health / Lippincott Williams And Wilfins.
  18.  Ivan Pedrosa, Md, Maryellen R. Sun, Md, Matthew Spencer, Md, Elizabeth M. Genega, Md, Aria F. Olumi, Md, William C. Dewolf, Md And Neil M. Rofsky, Md. Mr Imaging Of Renal Masses: Correlation With Findings At Surgery And Pathologic Analysis. Radiographics July 2008 28:985-1003.
  19.  MacLennan G; Cheng L; Capitulo 2: Neoplasms of the Kidney en Bostwick D; Cheng L. Urologic Surgical Pathology. Mosby, 2008, p. 78-173.
  20. Eble JN et al. Capitulo 1: Tumours of the Kidney en WHO Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press. Lyon, 2004. p. 7-85.
  21. Cancer Protocols and Checklists. College of American Pathology. Kidney: